Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow
Ekso Bionics (Nasdaq: EKSO), a leader in exoskeleton technology for medical and industrial applications, has scheduled its fourth quarter and full year 2024 financial results announcement for March 3, 2025, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to discuss financial results and recent business developments. Investors can participate via phone by dialing 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be available through a live broadcast and archive on the company's investor relations website.
Ekso Bionics (Nasdaq: EKSO), leader nella tecnologia degli esoscheletri per applicazioni mediche e industriali, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 3 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 13:30 PT / 16:30 ET nello stesso giorno per discutere i risultati finanziari e gli sviluppi aziendali recenti. Gli investitori possono partecipare telefonicamente componendo il numero 877-407-6184 (nazionale) o 201-389-0877 (internazionale). La chiamata sarà inoltre disponibile tramite una trasmissione in diretta e un archivio sul sito web delle relazioni con gli investitori dell'azienda.
Ekso Bionics (Nasdaq: EKSO), líder en tecnología de exoesqueletos para aplicaciones médicas e industriales, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el 3 de marzo de 2025, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a la 1:30 p.m. PT / 4:30 p.m. ET el mismo día para discutir los resultados financieros y los recientes desarrollos comerciales. Los inversores pueden participar por teléfono marcando 877-407-6184 (nacional) o 201-389-0877 (internacional). La llamada también estará disponible a través de una transmisión en vivo y un archivo en el sitio web de relaciones con inversores de la empresa.
Ekso Bionics (Nasdaq: EKSO), 의료 및 산업 응용 프로그램을 위한 외골격 기술의 선두주자, 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 3월 3일, 시장 마감 후로 예정했습니다. 회사는 같은 날 오후 1시 30분 PT / 오후 4시 30분 ET에 재무 결과 및 최근 사업 개발에 대해 논의하기 위해 컨퍼런스 콜을 개최할 것입니다. 투자자는 877-407-6184(국내) 또는 201-389-0877(국제)로 전화하여 참여할 수 있습니다. 이 통화는 회사의 투자자 관계 웹사이트를 통해 실시간 방송 및 아카이브로도 제공됩니다.
Ekso Bionics (Nasdaq: EKSO), leader dans la technologie des exosquelettes pour des applications médicales et industrielles, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et l'année entière 2024 pour le 3 mars 2025, après la clôture du marché. L'entreprise organisera une conférence téléphonique à 13h30 PT / 16h30 ET le même jour pour discuter des résultats financiers et des développements récents de l'entreprise. Les investisseurs peuvent participer par téléphone en composant le 877-407-6184 (domestique) ou le 201-389-0877 (international). L'appel sera également disponible via une diffusion en direct et un archive sur le site web des relations investisseurs de l'entreprise.
Ekso Bionics (Nasdaq: EKSO), ein führendes Unternehmen in der Exoskelett-Technologie für medizinische und industrielle Anwendungen, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für den 3. März 2025, nach Marktschluss, angesetzt. Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse und die jüngsten Geschäftsentwicklungen zu besprechen. Anleger können telefonisch teilnehmen, indem sie 877-407-6184 (inländisch) oder 201-389-0877 (international) wählen. Der Anruf wird auch über einen Live-Stream und ein Archiv auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments.
To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company’s website at www.eksobionics.com under “Presentations & Events” in the Investors section.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
Contact:
Stephen Kilmer
Investor Relations
Direct: (646) 274-3580
Email: skilmer@eksobionics.com
FAQ
When will Ekso Bionics (EKSO) release Q4 and full year 2024 earnings?
How can investors join EKSO's Q4 2024 earnings call?
What time is Ekso Bionics' (EKSO) Q4 2024 earnings call?
Where can I find EKSO's Q4 2024 earnings webcast?
